Judge approves Bayer’s $7.25 billion Roundup cancer settlement
What’s new: The deal covers future non-Hodgkin lymphoma claims too, with payouts averaging roughly $10,000 to $165,000.
A Missouri judge approved a nationwide settlement that could require Bayer to pay up to $7.25 billion over 20 years to resolve thousands of U.S. claims that Roundup caused non-Hodgkin lymphoma. St. Louis Circuit Judge Timothy Boyer signed off Friday on the deal, which covers people already diagnosed and others who may be diagnosed in future years. Individual payments are expected to range from about $10,000 to $165,000, based on exposure, age at diagnosis and illness severity. The agreement gives Bayer more certainty after years of costly litigation, even as the company continues to deny Roundup causes cancer. The settlement follows a U.S. Supreme Court ruling in June that undercut a key failure-to-warn argument in state court cases.